fbpx
QQQ
-2.25
346.76
-0.65%
DIA
-0.84
345.14
-0.24%
SPY
-0.67
425.93
-0.16%
TLT
-0.17
141.39
-0.12%
GLD
-0.64
175.35
-0.37%

Why MicroStrategy's Stock Is Trading Lower Today

May 17, 2021 3:13 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

MicroStrategy (NASDAQ:MSTR) shares are trading lower amid a weekend decline in the price of bitcoin. MicroStrategy holds bitcoin as a treasury asset.

MicroStrategy is currently down 7.18% to a price of $482.08. The stock's current volume for the day is 611.87 thousand, which is approximately 100.06% of its previous 30-day average volume of 611.52 thousand.

The 50-day moving average price of MicroStrategy's stock was $670.2 when this article was published. The stock reached a high of $1315.0 and a low of $109.64 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

Why MicroStrategy's Stock is Down During Today's Session

The Price And Volume Action In MicroStrategy's Stock Today MicroStrategy's (NASDAQ:MSTR) stock has been falling Friday, down 1.16% to a price of $590.98. The stock's current volume for the day is 104.57 thousand, which is approximately 16.2% of its previous 30-day average volume of 645.40 thousand. read more

Why Is It Moving? Looking Into Why MicroStrategy's Stock is Trading Lower Today

The Price And Volume Action In MicroStrategy's Stock Today MicroStrategy (NASDAQ:MSTR) is currently down 5.41% to a price of $885.51. The stock's volume is currently 104.14 thousand, which is roughly 8.93% of its recent 30-day volume average of 1.17 million. read more

60 Biggest Movers From Yesterday

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD). read more

38 Stocks Moving In Monday's Mid-Day Session

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV. read more